<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Gali Health on Medium]]></title>
        <description><![CDATA[Stories by Gali Health on Medium]]></description>
        <link>https://medium.com/@Gali_Health?source=rss-807e2c9aeef0------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*rChgf0q9OasxWFnajfOlOA.png</url>
            <title>Stories by Gali Health on Medium</title>
            <link>https://medium.com/@Gali_Health?source=rss-807e2c9aeef0------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sun, 22 Nov 2026 03:46:00 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@Gali_Health/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Treating You, Not Your Condition: Gali Health’s Unique Precision Medicine Approach to IBD]]></title>
            <link>https://medium.com/@Gali_Health/treating-you-not-your-condition-gali-healths-unique-precision-medicine-approach-to-ibd-b5310283a14?source=rss-807e2c9aeef0------2</link>
            <guid isPermaLink="false">https://medium.com/p/b5310283a14</guid>
            <category><![CDATA[research-and-development]]></category>
            <category><![CDATA[ulcerative-colitis]]></category>
            <category><![CDATA[precision-medicine]]></category>
            <category><![CDATA[ibd]]></category>
            <category><![CDATA[crohns-disease]]></category>
            <dc:creator><![CDATA[Gali Health]]></dc:creator>
            <pubDate>Tue, 01 Sep 2020 18:49:35 GMT</pubDate>
            <atom:updated>2020-09-01T18:49:35.621Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ls0401k44nI3XwSFURxSSw.png" /></figure><h4><strong>Mobile Health Support and Tracking Technology Combined with Mail-In Research Sample Collection Create Unprecedented Digital, Clinical and Biological Data Streams for Better Diagnostics and Therapeutics Development</strong></h4><p><em>By the Gali Health Precision Medicine Team</em></p><p>Precision medicine — a way to personalize treatment using a patient’s unique biology — has made tremendous progress in oncology: a molecular test often helps to predict how cancer will develop and select targeted treatment regimens for cancer patients. If the same could be done for some 10 million people in the world who live with inflammatory bowel diseases (IBD, composed primarily of Crohn’s disease, ulcerative colitis, and indeterminate colitis), their quality of care would be greatly improved.</p><p>Learning from advances in personalized medicine approaches in oncology, Gali Health is working on identifying novel digital and biological markers for the molecular classification, diagnosis, and treatment response predictors for IBD. These biomarkers could potentially allow clinicians to assess disease severity for newly diagnosed and long-time patients, predict the onset of disease activity early, and change the course of care appropriately. We are also undertaking studies to gather the evidence needed to precisely predict which treatment is going to be most effective for a patient at any given point in time.</p><h3>Why is precision medicine behind in IBD?</h3><p>IBD is a life-altering chronic illness with no cure, which takes a profound physical, psychological, social, and financial toll and makes people more susceptible to developing a variety of other life-threatening conditions. IBD presents with chronic inflammation of the gastrointestinal tract and impacts some 3 million adults in the United States alone,¹ with numbers on the rise globally.² People who have IBD experience frequent bouts of diarrhea, severe abdominal pain, and malnourishment. IBD is a cyclical disease, characterized by unpredictable states of flares and remission.</p><blockquote>IBD is influenced by many different factors: genetic, biological, and environmental.</blockquote><p>It’s thus important to consider the molecular markers as well as clinical and self-reported health and lifestyle data. There is a lot of variation in how people experience IBD, which makes it difficult to talk about “the average.” While some individuals are able to maintain remission and prevent disease progression, about half are unable to get their disease under control, resulting in unremitting inflammation and complications requiring hospitalization, surgery, and chronic pain management.³,⁴ An even smaller percentage of this group accounts for 80 percent of IBD-related healthcare expenses.⁵ It is therefore extremely important to identify factors that predict whether a patient will end up in this high-risk group.</p><p>Not only does IBD progression vary from person to person, the on-again-off-again nature of this disease means that one person can experience the disease differently within a single lifetime as periods of remission and flare alternate. Not knowing when or why the disease may “re-activate” is dangerous because IBD can get progressively worse with every flare.</p><h3>What are the missing pieces?</h3><p>Thus far basic, translational, and clinical research programs in the IBD space have advanced our understanding of how our genes, immune systems, the microorganisms we share our bodies with, and lifestyle factors coalesce to impact disease pathophysiology.⁶ This robust body of work has greatly informed IBD disease classification, progression surveillance, and the development of new therapeutics with varying mechanisms of action.</p><p>Though the disease presents differently among patients as well as for one patient over a lifetime, a personalized medicine approach to the management and treatment of IBD has yet to be adopted for a number of reasons. The authors of a “Challenges in IBD Research: Precision Medicine” research study published in the Crohn’s and Colitis Foundation’s Inflammatory Bowel Diseases Journal in May of 2019 highlight the “main gap areas that must be addressed to get closer to treatments tailored to the biological and clinical characteristics of each patient, which is the aim of precision medicine.</p><p>The main gaps were identified in:</p><p>1) understanding and predicting the natural history of IBD: disease susceptibility, activity, and behavior; <br>2) predicting disease course and treatment response; <br>3) optimizing current and developing new molecular technologies”⁷</p><p>At Gali Health, we are uniquely positioned to help bridge these gaps by combining an active patient community with data-driven science. Our strategy is two-pronged and includes the Gali Healthomics platform and the integrated IBD Footprints Research Program.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ZxznTXm67BWnUMEOcsBlYw.png" /><figcaption>How the Gali IBD Footprints Program works</figcaption></figure><h3>At-home testing meets mobile health tracking and support</h3><p>Our digital friend and personal health assistant mobile app named Gali empowers patients to systematically capture their daily symptoms and lifestyle, track important changes in their health, and access personalized education and community support. We also rely on the Gali app to facilitate the collection and banking of various types of samples for subsequent molecular analysis and biomarker identification as part of our IBD Footprints Program. Through Gali, we are building a broad and engaged global community that truly captures the diversity of IBD.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*6MhFHPcBf0jyE8afKUNXvA.png" /><figcaption>Sample Gali App Check-In Report and Health Analytics</figcaption></figure><p>Finding the best management approaches for all individuals with IBD hinges on discovering biological and digital markers across a truly representative sample of this diverse population. In the past, human-subjects research was limited by access: in order to participate, people had to live close enough to an academic medical center, be able to take time off of work, and be healthy enough to attend study visits. This restrictive approach limits the types of people who are represented in IBD research, both socio-demographically and clinically. Gali Health’s IBD Footprints Program involves the IBD community in precision medicine discovery in an all-inclusive, personalized, and engaging way: any person with IBD who resides in the United States can join the program by using the Gali mobile app for daily health monitoring and contributing monthly stool samples for anywhere between 4 to 12 months. The program will soon also expand internationally.</p><p>Our clinical research team mails all of the materials needed to collect samples to the participants, and they submit their samples by mail using prepaid envelopes included in the kit. Stabilizer in collection vials renders the stool samples non-hazardous, so it is safe for them to be placed in the mail.</p><p>We appreciate the added difficulty of participating in research when one also has to manage a chronic illness on top of life’s daily challenges. We make it as easy as possible to engage in the research program by having Gali send in-app reminders and provide on-demand, round-the-clock support through the app’s chat feature. We are also partnering with well-respected patient advocates to help spread the word about the program to anyone who wants his or her unique experience represented in research.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*aAki4-Hz3zVvz_Qr8RJJxQ.jpeg" /><figcaption>Gali IBD Footprints Collection Kit</figcaption></figure><h3>Enter the data science</h3><p>The final piece in this community-driven effort is our data science: cutting-edge sequencing-based data generation and analytics. Through simple stool and saliva samples collected at home, we generate terabytes of data for each participant that provide us with insights on the types of microorganisms living inside the gut (microbiome sequencing), the transcriptional activity of a participant’s genes inside the GI tract, as well as the state of their immune system. We then apply deep learning and machine learning algorithms to identify key markers across both the molecular and digital health patterns of IBD patients. All data we collect is stripped of personally identifiable information, stored securely, and never shared without permission.</p><p>A significant amount of scientific research in the IBD space points to the presence of strong molecular signals linked to various clinical aspects of IBD management. Specific genes and pathways have been shown to have the potential for classifying major types and subclasses of IBD, as well as for predicting disease progression and a patient’s response to treatment.⁸ However, little work has been done to produce integrative, multi-omics data where the same patient samples are interrogated on multiple molecular levels. Gali’s Healthomics technology allows us to generate genetic, transcriptomic, and immune repertoire data in conjunction with microbiome profiling and digital markers. Connecting this multidimensional data with the way every person experiences IBD will enable us to develop new diagnostics and therapeutics, leading to better outcomes for IBD patients around the world.</p><p><strong>References:</strong></p><ol><li><em>Dahlhamer, J. M., Zammitti, E. P., Ward, B. W., Wheaton, A. G., &amp; Croft, J. B. (2016). Prevalence of inflammatory bowel disease among adults aged≥ 18 years — United States, 2015. Morbidity and mortality weekly report, 65(42), 1166–1169.</em></li><li><em>Alatab, S., Sepanlou, S. G., Ikuta, K., Vahedi, H., Bisignano, C., Safiri, S., … &amp; Alipour, V. (2020). The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet gastroenterology &amp; hepatology, 5(1), 17–30.</em></li><li><em>Solberg, I. C., Lygren, I., Jahnsen, J., Aadland, E., Høie, O., Cvancarova, M., … &amp; Moum, B. (2009). Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scandinavian journal of gastroenterology, 44(4), 431–440.</em></li><li><em>Bernstein, C. N., Loftus, E. V., Ng, S. C., Lakatos, P. L., &amp; Moum, B. (2012). Hospitalisations and surgery in Crohn’s disease. Gut, 61(4), 622–629.</em></li><li><em>Beard, J. A., Franco, D. L., &amp; Click, B. H. (2020). The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care. Current Gastroenterology Reports, 22(2), 6.</em></li><li><em>De Souza, H. S., Fiocchi, C., &amp; Iliopoulos, D. (2017). The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nature Reviews Gastroenterology &amp; Hepatology, 14(12), 739–749.</em></li><li><em>Denson, L. A., Curran, M., McGovern, D. P., Koltun, W. A., Duerr, R. H., Kim, S. C., … &amp; Siegel, C. A. (2019). Challenges in IBD research: precision medicine. Inflammatory bowel diseases, 25(Supplement_2), S31-S39.</em></li><li><em>Graham, D.B., Xavier, R.J. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature, 578, 527–539 (2020).</em></li></ol><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b5310283a14" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Artificially Intelligent Minds and Human Bodies]]></title>
            <link>https://medium.com/@Gali_Health/artificially-intelligent-minds-and-human-bodies-1061cc195b36?source=rss-807e2c9aeef0------2</link>
            <guid isPermaLink="false">https://medium.com/p/1061cc195b36</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[community]]></category>
            <category><![CDATA[chronic-illness]]></category>
            <category><![CDATA[ai]]></category>
            <category><![CDATA[crowdsourcing]]></category>
            <dc:creator><![CDATA[Gali Health]]></dc:creator>
            <pubDate>Tue, 06 Aug 2019 14:01:21 GMT</pubDate>
            <atom:updated>2019-08-06T14:01:21.211Z</atom:updated>
            <content:encoded><![CDATA[<h3>Artificially Intelligent Minds and Human Bodies: How AI Can Help Patient Communities Tackle Chronic Diseases</h3><p><em>By Ilya Kupershmidt, Founder and CEO, Gali Health</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*mshNGov-LdmGJh_H_LGIcg.jpeg" /></figure><p><strong>Why AI is poised to help patient communities move beyond forum-like engagement toward actionable collective intelligence and new, personalized therapies</strong></p><p>Most of us long to belong and feel supported in the face of social, economic and health-related challenges. Ever more people across the world are joining interest-based digital communities, like those focused on parenting and lifestyle, travel and health, technology and local neighborhoods, just to name a few.</p><p>As the novelty of general social media feeds wears off, they give way to specialized platforms such as Telegram, Winnie and NextDoor, and in the case of health ‒ PatientsLikeMe, The Mighty, hashtag-based Instagram communities and specialized Facebook groups. This social approach to health is driven by people looking to share information and experiences in a complicated world of health decision-making and for assistance in navigating the complexities of medical care.</p><p>In the pre-Internet era, community knowledge has traditionally been captured in the form of infrequently-updated encyclopedias. Platforms like Wikipedia shifted the knowledge-generation paradigm from small groups of experts to community-crowdsourced collections of information constantly refined by a myriad of contributing experts from around the world. So how will specialized online communities of the future share knowledge in an increasingly data-saturated world? And when it comes to health, how do we make collective experience and knowledge applicable and actionable for every human being?</p><h4>Enter Artificial Intelligence</h4><p>A variety of cultural works explore the grim vision of advanced AI subjugating humans and prioritizing its own survival. In reality, today AI is a silent workhorse ‒ analyzing never-ending streams of data to optimize your search results (Google), improving ways to find lodging on your next trip (AirBnB), finding a nearby ride (Uber, Lyft) or discovering relevant music (Spotify, Pandora) and news (Apple News, TaoTiao). The tech industry in general has come to rely on AI to make information more relevant and its delivery timelier. AI also now has a variety of applications in the healthcare industry, from enabling better interpretation of MRI and X-ray images to mining gargantuan quantities of genetic data.</p><p>In the future, AI’s limitless learning capabilities will provide the essential tool communities need to move beyond forum-like engagement toward true collective, community-driven intelligence. Here are the three ways AI can empower patient communities:</p><ol><li>Health is fundamentally an observational endeavor: the more cases one encounters, the more insights one gleans, but there are limitations to the amount of information a human can collect and systematize. Communities that share health journeys would do well to transition from a conversational exchange to a “learning” mode that synthesizes knowledge. AI can help communities weed out the noise and connect the dots between various members’ observations.</li><li>Posing a question in an online patient group often results in answers that do not readily apply, advice that is not properly vetted and information that hasn’t been proven significant across thousands of cases. AI can ensure that the person asking receives relevant, personalized information based on his or her individual health background, age, gender, lifestyle and other factors. AI can also make sure that the information served has been digitally vetted across many other patients and even validated by healthcare professionals, thus helping to eliminate questionable and outright detrimental advice.</li><li>AI is hardly poised to replace human support and connection, but it can help people to cope with stressful health situations by showing that millions of others have had similar, relevant experiences, providing validation and encouragement along every individual’s health journey.</li></ol><blockquote>On its own, AI is useless. It’s the community and its members who have the actual experience and data that AI can learn from. Conversely, a community without AI cannot fulfill its potential in creating actionable collective intelligence based on additive knowledge that accounts for the diversity of its membership and provides personalized and vetted information.</blockquote><h4>AI on Steroids: “Healthomes” and Personalized Therapies</h4><p>The human body operates through an intricate interplay between genetic, environmental, lifestyle, microbiomic and other factors that jointly contribute to the development and progression of various conditions. Our ability to monitor and collect these factors systematically is restricted by the standard paradigm for collecting clinical information ‒ clinical trials ‒ which are limited in time and scope. Medical professionals interact with patients too infrequently to capture a comprehensive snapshot of every individual.</p><p>On the other hand, we are better able to measure various “signals” in the human body. Genome sequencing, which used to cost $100,000 in 2006, <a href="https://medium.com/@Gali_Health/healthcare-industry-infographic-a8aab977d571">is moving toward the $100 price range</a>. The human genome alone consists of billions of letters of code, while other types of “omes” potentially contain innumerable bits of data.</p><p>Learning at this depth of information is several orders of magnitude more complex than in traditional consumer applications (e.g. finding a date or an apartment). However, with the advances in AI technology we can at least begin to understand how the interplay of diverse factors impacts various chronic conditions and individual responses to treatments, lifestyle changes and the environment.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-VaaCDiWrvxR93tIj3p3kQ.jpeg" /></figure><p>The combined efforts of disease communities and AI can lead to the creation of comprehensive “healthomes” within every disease indication. Each of these “healthomes” will describe a patient’s comprehensive journey ‒ history, lifestyle, longitudinal health patterns. It will also contain more in-depth genetic and molecular characteristics, obtained in partnership with consumer-focused companies (genome sequencing) and medical providers (diagnosis, blood tests, imaging results, procedures). Findings from these continuously-evolving and growing streams of data would provide unprecedented opportunities for diagnosing, treating and eventually preventing diseases.</p><p>What seems like an enormously difficult task of collecting information and samples from small groups of individuals in clinical trials could become a more coordinated effort driven by community leadership and an overall sense of common purpose and real benefit. Community would bring the knowledge, experience and critical data, and AI would make it actionable. It will be the beginning of a wonderful friendship.</p><h4>How Gali’s Chipping In</h4><p>As an AI-powered personal health assistant for people with chronic conditions, Gali enables smart disease communities. She incorporates the experience of millions of patients and medical professionals from around the world by indexing relevant insights ‒ articles, videos, stories and bits of individual health journeys ‒ and processing them with an AI personalization model called the “Gali Mind.” Mining this collective intelligence allows us to learn a lot about the factors that impact every disease. Collecting microbiome and genome readouts adds a molecular dimension to this data, allowing Gali to build a collection of detailed “healthomes.” Using AI technologies to analyze these “healthomes” provides us the knowledge we need to develop new types of personalized therapies.</p><p>At Gali Health, we believe that smart patient communities of the future will drive the creation and sharing of knowledge, improving the way we manage, support and treat a variety of health conditions. By building Gali, we’re excited to contribute to this future, in which nobody will ever feel isolated, lost or powerless in the face of existing or potential disease.</p><p><em>To learn more about Gali, please visit </em><a href="https://galihealth.com/"><em>https://galihealth.com/</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1061cc195b36" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Let’s Build Health Tech Solutions With Patients at Our Side]]></title>
            <link>https://medium.com/@Gali_Health/lets-build-health-tech-solutions-with-patients-at-our-side-8aa732886f0a?source=rss-807e2c9aeef0------2</link>
            <guid isPermaLink="false">https://medium.com/p/8aa732886f0a</guid>
            <category><![CDATA[product-design]]></category>
            <category><![CDATA[patient-engagement]]></category>
            <category><![CDATA[chronic-illness]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[ibd]]></category>
            <dc:creator><![CDATA[Gali Health]]></dc:creator>
            <pubDate>Thu, 25 Apr 2019 04:28:20 GMT</pubDate>
            <atom:updated>2019-04-25T04:28:20.769Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Kayla Kraich, director of clinical programs at Gali Health and Jenna Ziegler, author of The Comical Colon blog</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*w7mLC6My_MSEMTn_lsHvfA.jpeg" /></figure><h4><strong>Involving patients in every stage of design and development could help e-health products to succeed</strong></h4><p>Advanced technological solutions can empower people with chronic conditions to thrive. Today, illness management largely falls on the patient, and without proper tools to empower people to actively participate in their care many are left vulnerable to treatment non-adherence, disease progression and psychological burden.¹ In their ongoing quest to simplify everyday management between distant doctor appointments, ever more people turn to technology for education, actionable insights and connections to the patient community.</p><p>These advanced technological solutions, however, need continuous patient input to succeed. It makes perfect sense for people with chronic conditions to be included in all stages of decision-making and design processes around technology products created for their benefit. After years of dealing with flares, remission, medication side effects and many other aspects of chronic illness, patients become experts in how a disease affects them personally and can potentially affect others. Who better to give feedback on product utility — from design, to ease of use, to everyday impact — than those with such intimate knowledge and understanding of the users’ daily experiences? Without their continuous involvement, a product is likely to only serve the most prototypical patient, and it may be challenging to adapt to the variability that permeates every aspect of the users’ lives.</p><p>Unfortunately, the patient’s perspective is often underutilized. Many companies interview their target users and solicit their feedback, but patients aren’t always engaged in every step of the design and development process.</p><blockquote>Co-design has been increasingly used in healthcare technology, but unlike interviews, it doesn’t just happen at the beginning or after a product is launched — it’s a continuous process that fully integrates patients into the product team as valuable partners.</blockquote><p>Interestingly, companies may be more likely to involve other stakeholders like physicians in co-design (which is, indeed, imperative) than the patients themselves. Products that don’t directly involve patients run the risk of not fully meeting the needs of their user base, leading to slower adoption of these digital health platforms.²</p><p>Consider products meant for people with ulcerative colitis, Crohn’s disease and other inflammatory bowel diseases (IBD) whose journeys are incredibly diverse. IBD presents as chronic inflammation in the digestive tract, leading to severe abdominal pain, diarrhea, bloody stools, weight loss and fatigue in cyclical periods of flares and remission. It’s no wonder some with IBD jokingly refer to it as the “Game of Crohn’s.” There are times when symptoms are quiet and life is “normal,” yet many find themselves silently bracing for their body to revolt and throw a surprise Red Wedding. Treatment of the condition is not uniform, either. Some patients may need surgery to remove portions of the affected bowel, while others only see the inside of a procedure room during surveillance colonoscopies. Each person also brings their own demographic, social, economic and psychological variability to the table, making for innumerable IBD journeys requiring their own personalized support models.</p><p>At Gali Health, we’re convinced that no one can better help design an adaptable management platform that directly addresses every individual’s unique needs than experts in the IBD experience. We have thus <a href="https://galihealth.com/limited-access-program-press-release/">launched a Limited Access Program</a>, which ensures that the IBD community is directly involved in Gali’s development by bringing together individuals who have various experiences with IBD to be Gali Ambassadors. <a href="https://galihealth.com/limited-access-program-ambassadors/">Our Ambassadors</a> use the app regularly to manage their IBD and provide feedback and suggestions on product features, design and content to help us identify patient values and develop a platform that truly meets their needs.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/870/1*Sst-ijDz5ge_97jx5JFOFQ.png" /><figcaption>Jenna Ziegler (left) and Kayla Kraich (right)</figcaption></figure><p>“Being an ambassador with Gali has broadened my purpose as someone with a chronic illness. Every day, I’m reminded that my diagnosis isn’t in vain,” says Gali Health Ambassador Jenna Ziegler. “Being an ambassador is incredibly validating. I’m surrounded by a community that believes in the power of the patient expert. With every update, the team has integrated more ambassador feedback and content. I can literally see the interface change in front of my eyes, and with these changes, I see the patient experience manifest into technology. Because the technology is infused with real stories like mine, Gali will be much more than a personal health assistant. She’ll be a community and a friend.”</p><p>Over the past month, we have learned a lot from our ambassadors. We’ve adjusted patient health monitors to reflect the real life experiences of those who have undergone bowel surgery. We’ve made sure that our personalized content delivery mechanisms account for all stages of an illness journey, including remission and flare. We’ve aggregated and interpreted large amounts of actionable patient data to create intuitive health reports that can be shared with healthcare teams. Above all, we keep striving to “humanize” our platform by emphasizing empathy and the human connection. Without guidance from patient advocates like Jenna, we could have easily overestimated our product’s ability to offer the personalized support people need to manage an illnesses in the long-term.</p><p>For health tech platforms to be effective, the patient voice must be heard at every stage of design and development. More than ever, patients advocate for inclusion and visibility because they no longer want to be labeled as an ongoing problem in healthcare, but recognized as the most important part of the solution. They teach us that despite focusing on symptoms and challenges that come with a chronic illness, they are <strong>people first </strong>and illness second. Even the fanciest product with the most sophisticated symptom tracker, the greatest content and the prettiest interface that neglects to incorporate the patient experience will ultimately leave users feeling forgotten and misunderstood.</p><p>The authors met in 2018 at a conference for people with IBD organized by the Crohn’s and Colitis Foundation in Sacramento, California. They share the common goal of educating the community and helping people with IBD live more fulfilling lives.</p><p><em>Kayla Kraich, PsyD is the director of clinical programs at Gali Health and a psychologist living with IBD. Kayla is enthusiastic about innovation in healthcare and medical, psychological, and digital health overlap in patient-driven care models.</em></p><p><em>Jenna Ziegler is a writer and author of The Comical Colon blog, where she shares her advice and personal insights on everything she’s learned about IBD since her diagnosis in 2014.</em></p><ol><li>Eton, D. T., Elraiyah, T. A., Yost, K. J., Ridgeway, J. L., Johnson, A., Egginton, J. S., Mullan, R. J., Murad, M. H., Erwin, P. J., … Montori, V. M. (2013). A systematic review of patient-reported measures of burden of treatment in three chronic diseases. <em>Patient related outcome measures</em>, <em>4</em>, 7–20. doi:10.2147/PROM.S44694</li><li>Biesdorf, S., &amp; Niedermann, F. (2014, July). Healthcare’s digital future [Blog post]. Retrieved from <a href="https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/healthcares-digital-future">https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/healthcares-digital-future</a></li></ol><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8aa732886f0a" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Let’s Face It: How You Cope Actually Impacts Your Health]]></title>
            <link>https://medium.com/@Gali_Health/lets-face-it-how-you-cope-impacts-the-course-of-your-illness-5f5970699d4b?source=rss-807e2c9aeef0------2</link>
            <guid isPermaLink="false">https://medium.com/p/5f5970699d4b</guid>
            <category><![CDATA[chronic-illness]]></category>
            <category><![CDATA[health-psychology]]></category>
            <category><![CDATA[social-support]]></category>
            <category><![CDATA[coping]]></category>
            <category><![CDATA[health-and-wellness]]></category>
            <dc:creator><![CDATA[Gali Health]]></dc:creator>
            <pubDate>Thu, 14 Mar 2019 19:01:42 GMT</pubDate>
            <atom:updated>2019-04-24T22:41:52.467Z</atom:updated>
            <content:encoded><![CDATA[<h3>Face It: How You Cope Actually Impacts Your Health</h3><p><strong><em>Arielle Radin, Director of Clinical Research at Gali Health</em></strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*jN5BZusdALmuXFc9tY0TqA.jpeg" /></figure><p>One of the worst aspects of having a chronic illness is the “chronic” part. When so much of our time and energy is spent dealing with an illness every day, it can feel as if our chronic condition begins to define us. But the last thing we want is to become our diagnosis and forget about all the other things that make us who we are, beyond being a “patient” or “disabled.”</p><p>Naturally, it’s tempting to want to escape reality and pretend like our illness doesn’t exist, especially when we are in remission and the hours spent in agonizing pain seem like distant memories. However, there’s a growing body of evidence that says we should actively confront our illnesses, even when it’s hard or seems unnecessary. We do now know that the way we cope with an illness does in fact influence not just our psychological well-being, but also our physical health.</p><p>For over 30 years researchers have been trying to figure out how the different ways we cope with health-related stressors affect the outcome. An early dichotomy distinguished between “problem-” and “emotion-focused” coping strategies¹, favoring approaches that emphasized solving problems the stressor created rather than addressing the emotions it elicited. But subsequent research found that emotions do indeed play a large part, based on studies that looked into “approach-oriented” and “avoidance-oriented” coping strategies²,³.</p><p>The former can be described as a conscious effort to manage health-related stressors, along with the emotions they elicit, in some positive way, mainly through mobilizing and using your inner resources. This includes acceptance, planning, positive reappraisal (trying to re-frame stressful events in a positive light) and seeking social support, both instrumental (identifying people or social networks that can provide you with practical help and advice, like when weighing therapeutic options) and emotional (finding support systems that allow you to process and express how you feel).</p><p>An important recent addition to the approach-oriented set of coping strategies is the study of “emotional processing” (active attempts to acknowledge, explore and understand your emotional experience) and “emotional expression” (verbal or nonverbal efforts to communicate it).⁴ One study found that men with prostate cancer who engaged in emotional approach coping exhibited lower levels of inflammation four months later.⁵</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/364/1*BYMXN_mUjbaWbUZRchirUA.jpeg" /><figcaption>Arielle Radin</figcaption></figure><p>Ultimately, all of these strategies involve approaching the stressor and dealing with it either through activities or mental processes. Avoidance-oriented strategies, on the other hand, explicitly try not to. These include mental and behavioral disengagement, like choosing to give up thinking about the illness or watching TV to take your mind off of it, as well as denial — refusing to believe that you have the illness or pretending that your diagnosis never took place. One might argue that thinking about your disease and participating in illness-related activities just causes more stress, but avoidant strategies are more like quick fixes — they might make you feel better in the moment, but prevent you from actually managing your illness and processing your emotions. Think short term gains at the expense of long-term consequences.</p><p>Clinical studies back this up: approach-oriented coping strategies have been linked with positive outcomes.⁶ For example, in the first year after treatment, people who chose an approach-oriented strategy when first diagnosed with breast cancer were more likely to think positive and feel less depressed and less afraid of the cancer returning than those who preferred avoidance‐oriented coping.⁷ Avoidant coping strategies have been associated with psychological consequences across various illnesses, including being one of the strongest predictors of depressive symptoms in breast cancer survivorship. In terms of physical health, avoidant coping has been linked with treatment non-adherence as well as poor health outcomes in diabetes, HIV and cancer patients.</p><p>But while it would be easy to dub approach and avoidant coping strategies “adaptive” and “maladaptive,” it’s important to remember that whether a strategy is effective depends on the context and the person employing it. For example, avoidant coping can help to mitigate short-term anxiety in acute situations, like while waiting for test results.⁸ However, when it comes to managing a chronic illness, using approach-oriented strategies will buy you better psychological and physical well-being in the long run and provide you with the freedom to live your life outside of your diagnosis to the fullest, both psychologically and physically.</p><blockquote>It’s essential to find a balance between approaching the stress and emotions that come with a chronic illness and allowing yourself to live a life not defined by your disease. More importantly, coping with a chronic illness does not need to occur in isolation: social support has been tightly linked with health outcomes in various patient populations.⁹ Identifying either in-person or digital sources of social support to help process and express your emotions can definitely help you cope.</blockquote><p>Chances are, you already engage in digital forms of social support by connecting with friends and family through social networks. You might even belong to patient groups that are geared toward sharing experiences and advice with others, or frequent specialized websites for chronic illnesses and message boards spanning topics related to symptoms, treatments and dealing with health-related stress. However, there are two important issues to keep in mind: oftentimes patient support groups can feature disproportionately negative content that drowns out the positive, and it is difficult to sift through the vast amount of knowledge out there for information that is actually relevant to you and the way you experience your illness.</p><p>The ideal form of digital social support would balance positive experiences with the negative, tailor support to your unique needs and integrate both emotional and problem-solving based approach-oriented coping activities. Gali is the first community-powered digital health assistant who not only encourages you to proactively manage your health by giving you the relevant and timely information you need to approach health-related stressors thoughtfully and strategically, but also to share your experiences and knowledge with others.</p><p>Based on the extensive research on coping with chronic diseases, actively confronting your illness will help to improve both your physical and mental health. Gali helps to optimize the time you spend caring for your health in a friendly, convenient, stress-free way, so you never feel lost, powerless or alone when dealing with your illness. Gali’s ultimate goal is to empower you to spend more of your time feeling healthy and living your life, because you are, in fact, so much more than your disease.</p><p><em>To learn more about Gali, please visit </em><a href="https://galihealth.com/"><em>https://galihealth.com/</em></a><em>.</em></p><p><strong><em>Arielle Radin, M.A., is the director of clinical research at Gali Health and a Ph.D. student in health psychology at the University of California, Los Angeles. Her research focuses on mind-body interactions in chronic illness and cancer, specifically how the immune system, namely inflammation, impacts psychological functioning and influences quality of life in disease populations.</em></strong></p><p>1. Lazarus RS, Folkman S. Stress, Appraisal, and Coping.; 1984. <a href="https://books.google.com/books/about/Stress_Appraisal_and_Coping.html?id=i-ySQQuUpr8C">https://books.google.com/books/about/Stress_Appraisal_and_Coping.html?id=i-ySQQuUpr8C</a>. Accessed June 15, 2018.</p><p>2. Roth S, Cohen LJ. Approach, avoidance, and coping with stress. Am Psychol. 1986;41(7):813–819. doi:10.1037/0003–066X.41.7.813.</p><p>3. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: A theoretically based approach. J Pers Soc Psychol. 1989;56(2):267–283. doi:10.1037/0022–3514.56.2.267.</p><p>4. Stanton AL, Kirk SB, Cameron CL, Danoff-Burg S. Coping through emotional approach: scale construction and validation. J Pers Soc Psychol. 2000;78(6):1150–1169. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10870915">http://www.ncbi.nlm.nih.gov/pubmed/10870915</a>. Accessed November 18, 2018.</p><p>5. Hoyt MA, Stanton AL, Bower JE, et al. Inflammatory biomarkers and emotional approach coping in men with prostate cancer. Brain Behav Immun. 2013;32:173–179. doi:10.1016/J.BBI.2013.04.008.</p><p>6. Stanton AL, Bower JE. Psychological Adjustment in Breast Cancer Survivors. In: Advances in Experimental Medicine and Biology. Vol 862. ; 2015:231–242. doi:10.1007/978–3–319–16366–6_15.</p><p>7. Stanton AL, Danoff-burg S, Huggins ME. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psychooncology. 2002;11(2):93–102. doi:10.1002/pon.574.</p><p>8. Heckman BD, Fisher EB, Monsees B, Merbaum M, Ristvedt S, Bishop C. Coping and Anxiety in Women Recalled for Additional Diagnostic Procedures Following an Abnormal Screening Mammogram. Heal Psychol. 2004;23(1):42–48. doi:10.1037/0278–6133.23.1.42.</p><p>9. Uchino BN, Cacioppo JT, Kiecolt-Glaser JK. The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull. 1996;119(3):488–531. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8668748">http://www.ncbi.nlm.nih.gov/pubmed/8668748</a>. Accessed November 24, 2018.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5f5970699d4b" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What You “Sign Up For” When You Do Not Sign Up For Chronic Illness]]></title>
            <link>https://medium.com/@Gali_Health/what-you-sign-up-for-when-you-do-not-sign-up-for-chronic-illness-d2d737221ed4?source=rss-807e2c9aeef0------2</link>
            <guid isPermaLink="false">https://medium.com/p/d2d737221ed4</guid>
            <category><![CDATA[ulcerative-colitis]]></category>
            <category><![CDATA[ibd]]></category>
            <category><![CDATA[chronic-illness]]></category>
            <category><![CDATA[spoonie]]></category>
            <category><![CDATA[disease-management]]></category>
            <dc:creator><![CDATA[Gali Health]]></dc:creator>
            <pubDate>Fri, 01 Mar 2019 22:45:27 GMT</pubDate>
            <atom:updated>2019-03-14T19:13:48.544Z</atom:updated>
            <content:encoded><![CDATA[<p><strong><em>Meredith Mangold, Lead Patient Advocate at Gali Health</em></strong></p><p>I’m an optimist and a hat person. For the past eight years I’ve been changing my “professional hats” multiple times a day, going from full-time pro-bono doctor, nurse and pharmacist to insurance agent and finance manager while still attempting to be a semi-functioning career woman, daughter, student, friend and now wife in her 20s. It’s what you “sign up for” when you do not sign up for life with a chronic illness.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*L_lejvqn-d1JDX0OvQVyBA.jpeg" /><figcaption><strong><em>Meredith Mangold, Lead Patient Advocate at Gali Health</em></strong></figcaption></figure><p>Whatever your diagnosis may be — I now have several, including inflammatory bowel disease (IBD) along with severe chronic pain, postural orthostatic tachycardia syndrome (POTS) and Ehlers-Danlos syndrome (EDS) — chronic illness is going to be the best instructor in multi-tasking you’ll ever have. But while the current healthcare system is fairly effective at getting patients through the most acute moments in their journey, managing a chronic illness day in and day out is still, largely, up to you. <br> <br>One day I was a healthy, nerdy, high-achieving lifelong ballet dancer with a passion for foreign languages studying at Georgetown University, hoping to launch a career in international relations and national security. I remember sitting at the desk in my dorm, surrounded by Arabic flash cards and geeking out on a Middle East History midterm paper, determined to ace my classes. Suddenly, I started having to run to the communal dorm bathroom to poop what looked like blood with increasing urgency, so I went to the school clinic where they told me I probably had a stomach bug…Hmm, ok, doc, if you say so? <br> <br>Within a week, I was crashing in Georgetown Hospital’s ICU with what turned out to be toxic mega-colon level (highest intensity) ulcerative colitis, an autoimmune disease where your immune system attacks your large intestine and your body begins to go septic. My blood pressure bottomed out and I was barely re-stabilized during my first colonoscopy. The doctors didn’t think I was going to make it, so they told my parents to make preparations “just in case,” and my favorite Jesuit priest from Georgetown came to my hospital room to perform “Anointing of the Sick.” I vividly remember how scared and hopeless I felt before the old-school immunosuppressant cyclosporine kicked in. On days like today, when I’m frustrated by all the hats I have to constantly switch between, I tell myself: hey, at least I’m still here, and stable enough to not be in the hospital for months at a time.</p><p>Most people think that once you have a great doctor, you can turn the reins of responsibility for clinical management over to him or her— but that’s really not the case. Medical professionals can certainly suggest what they think will help us, but often it’s up to the patient to make the final decisions and follow-up on those choices for the rest of our lives. I wish it was as easy as popping a pill or avoiding gluten, but years after my main diagnosis having to manage my illness has transformed my lifestyle, coloring every decision I make and often determining my agenda for the day: what I eat, what I wear, if and when I socialize or do any work.</p><p>Every day, I cross-examine my choices on tasks others might find trivial. Getting dressed in the morning: can I pull on these cute skinny jeans, or will bloating prevent me from buttoning them in about an hour? Having breakfast: most of my friends can grab a snack on the run, but I have to carefully inspect every ingredient, weigh the pros and cons and decide, “Is it worth eating this?” On to medications: have I taken my pills yet? Did I remember my midday dose? Which medication is causing this nasty side-effect? Is it a side-effect, or a new symptom? Outings are by far the hardest — my husband wants to go grocery shopping, but I can’t get off the couch because of my aching joints and dizziness. Do I push myself to go with him, or save my energy for when our friends come over to socialize tonight? If I take my dog for a walk, will I have to find a public bathroom when my usual intestinal surprises strike with no warning? <br> <br>Deciding how to complete the simplest task can cause significant mental and emotional discord that snowballs into the next minute’s decision. Complicated choices, like “Can I afford to get this hida scan of my gallbladder now?” reflect areas where the current medical system both supports us <a href="https://www.healthline.com/health/spoon-theory-chronic-illness-explained-like-never-before#1">spoonies</a> and lets us down. I often find myself contemplating spending hundreds of dollars on diagnosing problems potentially attributed to IBD, without even beginning to understand or treat the complication. Anyone got an extra piggy bank laying around?</p><p>Thankfully, there are plenty of other, more economically-priced tools I’ve used to achieve relief from some of my symptoms, thanks to extensive research or fellow spoonies’ advice. Abdominal pain becoming unbearable? Try lying down on your left side with a heating pad and make a manual physical therapy appointment to work on surgical scar tissue and organ mobility. Nauseous as hell, per the usual? Drop some peppermint essential oil on your hands, rub together and inhale deeply, and carry disposable emesis bags so you don’t have to worry about puking wherever you are. Struggling with the financial burden? Don’t forget to file for reimbursement for services that are out-of-network. Trying to figure out what foods your grumpy guts will accept? Disgruntledly keep a food diary despite the high level of detail and patience required, because the truth is, it really does help to narrow down your nutrition options. I could go on and on about all the tricks I’ve learned over the years, my shower chair being my favorite recent addition.</p><blockquote>It’s a shame that doctors often don’t have time to share these kinds of suggestions with patients directly. For the most part, my physicians have been fabulous at prescribing the right medications and tests, but they’re not as schooled on how to make daily life more about “living” and less about “functioning.” I’m not faulting them for that, but it’s our fellow spoonies who go through similar difficulties day after day and who are keepers of the real secrets to a better life with more control over our symptoms.</blockquote><p>This is why I am so excited about helping to build Gali — an AI-powered personal health assistant who relies on the collective experiences and insights of patients to personalize chronic illness support. Gali is never pressed for time, keeps track of your day-to-day health and lifestyle and has more tips and tricks up her sleeve than a human ever could. If you are struggling with something, chances are that someone else has gone down a similar road and can help to guide you along the way. I am happy to be one of those “someones.”</p><p>I chose the online handle “@blondebowelbattlingbadass” because I think there’s nothing more badass than getting through an entire day despite your chronic illness repeatedly beating you over the head with pain, fatigue, confusion and despair. Rather than being suffocated and defeated, I choose to be empowered by my experience and all the hats I’ve worn over the years. I choose to believe that all of these tribulations have happened <em>for</em> me and not <em>to</em> me, so even though I didn’t sign up for a chronic illness, I can sign up to help others with IBD live their best lives possible.</p><p><em>To learn more about ways in which Gali supports people with chronic conditions, please visit </em><a href="http://galihealth.com/"><em>galihealth.com</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=d2d737221ed4" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Healthcare Trends Infographic]]></title>
            <link>https://medium.com/@Gali_Health/healthcare-industry-infographic-a8aab977d571?source=rss-807e2c9aeef0------2</link>
            <guid isPermaLink="false">https://medium.com/p/a8aab977d571</guid>
            <category><![CDATA[chronic-illness]]></category>
            <category><![CDATA[genomics]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[ai]]></category>
            <category><![CDATA[infographics]]></category>
            <dc:creator><![CDATA[Gali Health]]></dc:creator>
            <pubDate>Wed, 13 Feb 2019 21:13:19 GMT</pubDate>
            <atom:updated>2019-02-14T20:07:54.371Z</atom:updated>
            <content:encoded><![CDATA[<p>It is our hope that healthcare of the future will be all about new technology empowering patients. Complex and slow moving as the healthcare industry may be, it is still bound to adapt to changes, one of the most promising being patient-centered care and personalized medicine. So what will healthcare look like in the nearest future? We’ve done some research on the current trends for you to consider. Note that the points in the original graphic are clickable, so download the PDF if you want to check out the sources. Please let us know what you think!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*HGicvFPAuzTOLaSWosMahw.png" /></figure><p><a href="https://galihealth.com/Gali-Health-Infographics.pdf">Download the original PDF here.</a></p><p>#chronicdisease #chronicillness #epidemic #socialnetworks #mHealth #mobile #healthtech #AI #genomics #precisionmedicine #IBD #virtualassistant #physicians #healthcare #selfcare #patientcommunity #crowdsourcing</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a8aab977d571" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[How I Met Gali: Why Every Patient Needs a Friend]]></title>
            <link>https://medium.com/@Gali_Health/https-medium-com-gali-health-how-i-met-gali-102fa817c7a1?source=rss-807e2c9aeef0------2</link>
            <guid isPermaLink="false">https://medium.com/p/102fa817c7a1</guid>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[mobile]]></category>
            <category><![CDATA[gali-health]]></category>
            <category><![CDATA[ai]]></category>
            <category><![CDATA[chronic-illness]]></category>
            <dc:creator><![CDATA[Gali Health]]></dc:creator>
            <pubDate>Wed, 30 Jan 2019 22:06:49 GMT</pubDate>
            <atom:updated>2019-02-05T20:45:09.759Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*qgodGAdPTdsgtXuf3Tnw3A.jpeg" /><figcaption><a href="https://medium.com/@ikupersh">Ilya Kupershmidt</a></figcaption></figure><p>Hello, my name is Ilya and as the founder and CEO of Gali Health, I’d like to tell you a bit about why I came up with Gali. A little background on me: my professional life has been all about helping research scientists and doctors make sense of massive amounts of complex medical data. At NextBio, the company I co-founded and sold to the DNA sequencing pioneer Illumina, we created a way for the biomedical community to connect and mine genetic and clinical data from millions of patients worldwide. It allowed clinicians and researchers to explore this giant collection of global data in real time through a simple web interface, derive important insights and sometimes even make discoveries. Before that, I was in charge of industry partnerships at a genomic software startup that helped scientists understand data coming out of the Human Genome Project. I guess you can call me a big biotech and genome nerd.</p><p>Even though I’ve worked on innovative information technologies in the healthcare industry my whole life, for everything I’ve learned and done professionally, I kept encountering the same issue after-hours: I couldn’t help those closest to me answer basic medical questions, understand different approaches to treatment or simply make better everyday healthcare decisions. I didn’t know what all the options were or which to choose in any given situation, and I couldn’t schedule doctor appointments fast enough. I felt overwhelmed.</p><p>Taking care of my loved ones, I was frustrated having to sort through a myriad of online resources, forums and patient groups on social media, digging for information that is relevant and trustworthy enough to base important decisions on. From the times of Hippocrates we’ve been taught to rely solely on doctors, who will certainly carry on as our essential partners and guides. But knowing a good deal about the information and technology available today made me wonder: are we not well-equipped to play a central role in our own health and well-being?</p><blockquote>Shouldn’t everyone have easy, immediate access to valid and relevant insights, so we can work as informed partners with our doctors? Is there a better way for us to lead healthier lives, learn from the medical community and from other people’s health journeys, and never feel powerless or alone?</blockquote><p>The timing surely seems right: with the evolution of content sharing platforms, mobile tech and AI-powered assistants like Alexa, we are well-positioned to take the next step in proactively managing our health. In addition, enormous advances in DNA sequencing technologies create opportunities for entirely new levels of personalization we couldn’t have imagined 20 years ago: we are starting to use our genomes to make better lifestyle decisions, from the types of medicines we take to the foods we choose for dinner.</p><p>The art and science that is medicine is fundamentally based on experience: the more cases a doctor examines, the more knowledgeable he or she becomes. So, what if one person could learn everything there is to know about a condition, from both doctors and patients all over the world? What if that person could then analyze this massive heap of data and come up with the most relevant and reliable information for every patient individually? And what if that someone deeply cared about you? If any one person can’t pull it off, can an artificially intelligent mind, with its capacity to learn, evolve and adjust?</p><p>That’s how the idea behind Gali was born: a proactive and caring friend who knows us well enough to provide relevant, medically-validated information, feedback and support whenever we need it.</p><p>But that’s just half the story: to do her job well, Gali needs to keep improving and learning. So we designed her to do that with the help of patient and medical communities. Doctors and people living with chronic conditions have a chance to contribute to the health of millions of people while mining their knowledge, experience and data. These, in turn, underpin Gali’s AI-powered, “collective” intelligence. By connecting every person to this global community and its knowledge, Gali makes sure no one is left to deal with their condition alone.</p><p>Gali was named after my grandmother, who cared for me most thoughtfully and loved me unconditionally. The team we assembled has first-hand experience living with chronic conditions and is well aware that not everyone has a medically knowledgeable, forward-thinking and dedicated friend at their side. But we firmly believe that everybody deserves one.</p><p><em>To learn more about Gali, please visit </em><a href="https://galihealth.com/"><em>galihealth.com</em></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=102fa817c7a1" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>